NCT03404804View on ClinicalTrials.gov

Oral Challenge in the Pediatric ED

PHASE4CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

December 4, 2017

Primary Completion Date

December 4, 2020

Study Completion Date

December 4, 2022

Conditions
Penicillin AllergyPediatric Emergency Medicine
Interventions
DRUG

Amoxicillin

Oral challenge with amoxicillin in patients who are deemed low-risk for true penicillin allergy

Trial Locations (1)

53226

David Vyles, Milwaukee

All Listed Sponsors
lead

Medical College of Wisconsin

OTHER

NCT03404804 - Oral Challenge in the Pediatric ED | Biotech Hunter | Biotech Hunter